Oocyte Freezing for Fertility Preservation in Benign Ovarian Tumors

NCT03823833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2025-12-23

No results posted yet for this study

Summary

Benign ovarian cysts are frequent during women's life. They are diagnosed with pelvic pain or fortuitously during an ultra-sonographic exam. In case of persistence,a surgery will be necessary to identify the nature of the cyst and assess its benignity. In some case, cysts are recurrent and multiple surgeries are needed leading to a significant risk of ovarian damage by follicular depletion. Oocyte cryopreservation is no longer considered as an experimental technique of Fertility Preservation since 2013 as it has been recognized to be efficient and safe. According to reproductive medicine scientific committees and the French ethic law, fertility preservation has to be proposed in every situation of infertility risk. To date, there is no cohort study dedicated to fertility preservation by oocyte freezing in this specific subgroup of patients. The purpose of the study is to prospectively evaluate the oocyte number and quality after controlled ovarian hyperstimulation in patients with recurrent ovarian cysts.

Conditions

  • Endometriosis
  • Dermoid Cyst
  • Mucinous Cyst

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Christine Decanter, MD · University Hospital, Lille

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-28
Primary Completion
2025-04-04
Completion
2025-04-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03823833 on ClinicalTrials.gov